{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:23:57Z","timestamp":1790821437081,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok","doi-asserted-by":"publisher","award":["NKFIH K115398"],"award-info":[{"award-number":["NKFIH K115398"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1210\/jc.2018-00817","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T14:09:57Z","timestamp":1529590197000},"page":"3522-3530","source":"Crossref","is-referenced-by-count":32,"title":["MicroRNA Expression Profiling in Adrenal Myelolipoma"],"prefix":"10.1210","volume":"103","author":[{"given":"Abel","family":"Decmann","sequence":"first","affiliation":[{"name":"Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Perge","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Ny\u00edr\u0151","sequence":"additional","affiliation":[{"name":"MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ott\u00f3","family":"Darvasi","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Lik\u00f3","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Borka","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Faculty of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Micsik","sequence":"additional","affiliation":[{"name":"First Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Pezzani","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[{"name":"Minimally Invasive Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Igaz","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary"},{"name":"MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"issue":"5","key":"key\n\t\t\t\t20180906135343_B1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"key\n\t\t\t\t20180906135343_B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180906135343_B3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-017-1473-4","article-title":"Adrenal myelolipoma: a comprehensive review","volume":"59","author":"Decmann","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B4","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/ERC-16-0564","article-title":"Lipomatous tumours in adrenal gland: WHO updates and clinical implications","volume":"24","author":"Lam","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"key\n\t\t\t\t20180906135343_B5","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer"},{"issue":"5","key":"key\n\t\t\t\t20180906135343_B6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"issue":"12","key":"key\n\t\t\t\t20180906135343_B8","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180906135343_B9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: a 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"key\n\t\t\t\t20180906135343_B11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1536-1632(02)00018-5","article-title":"2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma","volume":"4","author":"Ludwig","year":"2002","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"key\n\t\t\t\t20180906135343_B12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.mam.2012.06.005","article-title":"miRNAs and cancer: an epigenetics view","volume":"34","author":"Malumbres","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"4","key":"key\n\t\t\t\t20180906135343_B13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Chabre","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00018-014-1752-7","article-title":"MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy","volume":"72","author":"Igaz","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"key\n\t\t\t\t20180906135343_B15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surgery"},{"issue":"5","key":"key\n\t\t\t\t20180906135343_B16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"key\n\t\t\t\t20180906135343_B17","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1038\/s41598-017-05777-0","article-title":"Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors","volume":"7","author":"Perge","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"key\n\t\t\t\t20180906135343_B18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/labinvest.2013.148","article-title":"Analysis of circulating microRNAs in adrenocortical tumors","volume":"94","author":"Szab\u00f3","year":"2013","journal-title":"Lab Invest"},{"issue":"8","key":"key\n\t\t\t\t20180906135343_B21","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.25724","article-title":"MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy","volume":"117","author":"Patterson","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"key\n\t\t\t\t20180906135343_B22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"8","key":"key\n\t\t\t\t20180906135343_B23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.humpath.2014.04.005","article-title":"MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations","volume":"45","author":"Duregon","year":"2014","journal-title":"Hum Pathol"},{"issue":"24","key":"key\n\t\t\t\t20180906135343_B24","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer","volume":"15","author":"Soon","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20180906135343_B25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jhbp.524","article-title":"Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma","volume":"25","author":"Takahasi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"key\n\t\t\t\t20180906135343_B26","doi-asserted-by":"crossref","unstructured":"Li M, Song Q, Li H, Lou Y, Wang L. Circulating miR-25-3p and miR-451a may be potential biomarkers for the diagnosis of papillary thyroid carcinoma. PLoS One. 2015;10(7):e0132403.","DOI":"10.1371\/journal.pone.0132403"},{"issue":"2","key":"key\n\t\t\t\t20180906135343_B27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/or.2016.4854","article-title":"miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: the underlying molecular mechanisms","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol Rep"},{"key":"key\n\t\t\t\t20180906135343_B28","doi-asserted-by":"crossref","unstructured":"Babapoor S, Fleming E, Wu R, Dadras SS. A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion. PLoS One. 2014;9(9):e107502.","DOI":"10.1371\/journal.pone.0107502"},{"issue":"2","key":"key\n\t\t\t\t20180906135343_B29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.gene.2016.06.014","article-title":"Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer","volume":"591","author":"Tian","year":"2016","journal-title":"Gene"},{"issue":"6","key":"key\n\t\t\t\t20180906135343_B30","first-page":"8942","article-title":"MiR-486-5p prevents migration, invasion and EMT by regulating Smad2 in breast cancer","volume":"10","author":"Tan","year":"2017","journal-title":"Int J Clin Exp Med"},{"issue":"60","key":"key\n\t\t\t\t20180906135343_B31","doi-asserted-by":"crossref","first-page":"101649","DOI":"10.18632\/oncotarget.21417","article-title":"MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"key\n\t\t\t\t20180906135343_B32","first-page":"148","article-title":"MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA","volume":"7","author":"Liu","year":"2017","journal-title":"Am J Cancer Res"},{"issue":"11","key":"key\n\t\t\t\t20180906135343_B33","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1007\/s13277-016-5313-6","article-title":"Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol"},{"issue":"34","key":"key\n\t\t\t\t20180906135343_B34","doi-asserted-by":"crossref","first-page":"55395","DOI":"10.18632\/oncotarget.10577","article-title":"MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment","volume":"7","author":"Leoncini","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"key\n\t\t\t\t20180906135343_B35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"key\n\t\t\t\t20180906135343_B36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ajh.21863","article-title":"MicroRNAs: emerging key regulators of hematopoiesis","volume":"85","author":"Havelange","year":"2010","journal-title":"Am J Hematol"},{"issue":"21","key":"key\n\t\t\t\t20180906135343_B37","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s00018-014-1682-4","article-title":"Tumor surveillance by circulating microRNAs: a hypothesis","volume":"71","author":"Igaz","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"key\n\t\t\t\t20180906135343_B38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/stem.1549","article-title":"A novel negative regulator of adipogenesis: microRNA-363","volume":"32","author":"Chen","year":"2014","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20180906135343_B39","doi-asserted-by":"crossref","unstructured":"Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer. 2013;132(7):1633\u20131645.","DOI":"10.1002\/ijc.27840"},{"issue":"10","key":"key\n\t\t\t\t20180906135343_B40","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.tibs.2016.08.004","article-title":"Extracellular miRNA: a collision of two paradigms","volume":"41","author":"Turchinovich","year":"2016","journal-title":"Trends Biochem Sci"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/9\/3522\/25685969\/jc.2018-00817.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T16:52:30Z","timestamp":1571503950000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/9\/3522\/5041928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,6,21]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-00817","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,6,21]]}}}